Literature DB >> 11795950

Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression.

Tanya J Shaw1, Eniko J Keszthelyi, Angela M Tonary, Michaela Cada, Barbara C Vanderhyden.   

Abstract

C-KIT encodes a tyrosine kinase receptor (KIT) that, when activated by its ligand (KL), stimulates proliferation, differentiation, migration, and survival. Greater than 70% of epithelial ovarian cancers coexpress c-KIT and KL. C-KIT and KL expression levels have been shown to be up-regulated by cAMP in some cell types. Additionally, cAMP is well-recognized for its anti-proliferative effects in cancer cells. The goal of these experiments was to investigate these seemingly contradictory consequences of cAMP treatment by: (1) confirming the growth inhibitory actions of cAMP on ovarian cancer cells; (2) investigating the ability of cAMP to affect c-KIT and KL expression in these cells; and (3) examining the possible role of endogenous and/or cAMP-regulated c-KIT and KL expression in ovarian cancer cell proliferation. HEY cells, an ovarian cancer cell line which expresses c-KIT and KL, were treated with dibutyryl cyclic AMP (dbcAMP), 8-bromo-cAMP, and cholera toxin over a range of concentrations. With all treatments, stimulation of cAMP signaling caused a dose-dependent inhibition of HEY cell proliferation by up to 40, 62, and 38%, respectively. This inhibition of proliferation correlated with a dose-dependent increase in c-KIT mRNA expression, yielding 4- to 7-fold elevations in transcript abundance; there were no changes in steady-state levels of KL transcripts. In order to determine whether KIT expression/activity was responsible for the observed decrease in proliferation, dbcAMP-treated HEY cells were exposed either to anti-KIT neutralizing antibodies or to the KIT inhibitor STI571. These experiments demonstrated that KIT inhibition did not alter the growth rate of cells or reverse the dbcAMP-induced inhibition of proliferation. These results suggest that cAMP signaling pathways regulate both cell proliferation and c-KIT expression in ovarian cancer cells; however, KIT is not assuming its well-established role as a growth factor. Copyright 2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11795950     DOI: 10.1006/excr.2001.5426

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  16 in total

1.  Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events.

Authors:  Nathan J Charles; Peter Thomas; Carol A Lange
Journal:  Horm Cancer       Date:  2010-08       Impact factor: 3.869

Review 2.  Signaling of c-kit in dendritic cells influences adaptive immunity.

Authors:  Prabir Ray; Nandini Krishnamoorthy; Timothy B Oriss; Anuradha Ray
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

3.  Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line.

Authors:  M F Shi; J Jiao; W G Lu; F Ye; D Ma; Q G Dong; X Xie
Journal:  Cell Mol Life Sci       Date:  2010-06-12       Impact factor: 9.261

4.  Bone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth.

Authors:  Leandro E Mainetti; Xiaoning Zhe; Jonathan Diedrich; Allen D Saliganan; Won Jin Cho; Michael L Cher; Elisabeth Heath; Rafael Fridman; Hyeong-Reh Choi Kim; R Daniel Bonfil
Journal:  Int J Cancer       Date:  2014-05-20       Impact factor: 7.396

Review 5.  Emerging functions of c-kit and its ligand stem cell factor in dendritic cells: regulators of T cell differentiation.

Authors:  Prabir Ray; Nandini Krishnamoorthy; Anuradha Ray
Journal:  Cell Cycle       Date:  2008-09-07       Impact factor: 4.534

6.  Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment.

Authors:  Trisha S Tavares; David Nanus; Ximing J Yang; Lorraine J Gudas
Journal:  Cancer Biol Ther       Date:  2008-10-09       Impact factor: 4.742

Review 7.  Dendritic cell c-kit signaling and adaptive immunity: implications for the upper airways.

Authors:  Timothy B Oriss; Nandini Krishnamoorthy; Prabir Ray; Anuradha Ray
Journal:  Curr Opin Allergy Clin Immunol       Date:  2014-02

Review 8.  Cyclic phosphatidic acid - a unique bioactive phospholipid.

Authors:  Yuko Fujiwara
Journal:  Biochim Biophys Acta       Date:  2008-05-23

9.  A conserved quadruplex motif located in a transcription activation site of the human c-kit oncogene.

Authors:  Himesh Fernando; Anthony P Reszka; Julian Huppert; Sylvain Ladame; Sarah Rankin; Ashok R Venkitaraman; Stephen Neidle; Shankar Balasubramanian
Journal:  Biochemistry       Date:  2006-06-27       Impact factor: 3.162

10.  Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis.

Authors:  Jian-peng Teoh; Kyoung-mi Park; Yongchao Wang; Qiuping Hu; Sangmi Kim; Guangyu Wu; Shuang Huang; Nita Maihle; Il-man Kim
Journal:  Cell Signal       Date:  2014-09-03       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.